Cost-effective analysis of proton pump inhibitors in long-term management of Gastroesophageal reflux disease: a narrative review

Jamshed, Shazia Qasim and Bhagavathula, Akshaya Srikanth and Qadar, Sheikh Muhammad Zeeshan and Alauddin, Umaira and Shamim, Sana and Hasan, Sohail (2020) Cost-effective analysis of proton pump inhibitors in long-term management of Gastroesophageal reflux disease: a narrative review. Hospital Pharmacy, 55 (5). pp. 292-305. ISSN 0018-5787 E-ISSN 1945-1253 (In Press)

	PDF (Evidence from publisher's website for MYRA) - Published Version Restricted to Repository staff only Download (70kB) | Request a copy
Preview	PDF (Scopus) - Supplemental Material Download (264kB) | Preview
Preview	PDF (wos) - Supplemental Material Download (86kB) | Preview

Abstract

Background: Gastroesophageal reflux disease (GERD) is a common gastrointestinal disorder that results from regurgitation of acid from the stomach into the esophagus. Treatment available for GERD includes lifestyle changes, antacids, histamine-2 receptor antagonists (H2RAs), proton pump inhibitors (PPIs), and anti-reflux surgery. Aim: The aim of this review is to assess the cost-effectiveness of the use of PPIs in the long-term management of patients with GERD. Method: We searched in PubMed to identify related original articles with close consideration based on inclusion and exclusion criteria to choose the best studies for this narrative review. The first section compares the cost-effectiveness of PPIs with H2RAs in long-term heartburn management. The other sections shall only discuss the cost-effectiveness of PPIs in 5 different strategies, namely, continuous (step-up, step-down, and maintenance), on-demand, and intermittent therapies. Results: Of 55 articles published, 10 studies published from 2000 to 2015 were included. Overall, PPIs are more effective in relieving heartburn in comparison with ranitidine. The use of PPIs in managing heartburn in long-term consumption of nonsteroidal anti-inflammatory drug (NSAID) has higher cost compared with H2RA. However, if the decision-maker is willing to pay more than US$174 788.60 per extra quality-adjusted life year (QALY), then the optimal strategy is traditional NSAID (tNSAID) and PPIs. The probability of being cost-effective was also highest for NSAID and PPI co-therapy users. On-demand PPI treatment strategy showed dominant with an incremental cost-effectiveness ratio of US$2197 per QALY gained and was most effective and cost saving compared with all the other treatments. The average cost-effectiveness ratio was lower for rabeprazole therapy than for ranitidine therapy. Conclusion: Our review revealed that long-term treatment with PPIs is effective but costly. To achieve long-term cost-effective approach, we recommend on-demand approach to treat heartburn symptoms, but if the symptoms persist, treatment with continuous step-down therapy should be applied.

Item Type:	Article (Journal)
Additional Information:	6803/87990
Uncontrolled Keywords:	proton pump inhibitors, cost-effectiveness, economic evaluation, heartburn,gastroesophageal reflux disease, long-term management
Subjects:	R Medicine > RC Internal medicine
Kulliyyahs/Centres/Divisions/Institutes (Can select more than one option. Press CONTROL button):	Kulliyyah of Pharmacy > Department of Pharmacy Practice
Depositing User:	Dr Shazia Jamshed
Date Deposited:	21 Jan 2021 19:35
Last Modified:	21 Jan 2021 19:35
URI:	http://irep.iium.edu.my/id/eprint/87990

Actions (login required)

View Item